Hillview Capital Advisors, LLC
Follow13F filer, CIK 1631615, Wayne, PA
Hillview Capital Advisors, LLC reported $18,752,000 across 6 holdings for the quarter ended 2019-06-30, in a 13F-HR filed 2019-08-01.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-19-001601
- Period
- 2019-06-30
- Reported value
- $18.8M
- Holdings
- 6
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| VEAreduced | -7,054 | -$294K |
| VTreduced | -2,489 | -$187K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2019
Share positions as resolved from 13F-HR 0001172661-19-001601, largest first. % of portfolio is the value over $18,752,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| VEAVANGUARD TAX-MANAGED FDS | 237,766 | $9.92M | 52.89% | -7,054 | Timeline | ||
| VTVANGUARD INTL EQUITY INDEX F | 73,372 | $5.51M | 29.41% | -2,489 | Timeline | ||
| SCHDSCHWAB STRATEGIC TR | 53,500 | $2.86M | 15.26% | 0 | Timeline | ||
| VIGVANGUARD SPECIALIZED FUNDS | 1,919 | $221K | 1.18% | 0 | Timeline | ||
| AMZNAMAZON COM INC | 113 | $214K | 1.14% | 0 | Timeline | ||
| INNOVATE BIOPHARMACEUTICLS IINNOVATE BIOPHARMACEUTICLS I | 19,610 | $23K | 0.12% | 0 |
How Q2 2019 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001172661-19-001601 | base | 2019-08-01 | acceptance time not in the bulk data set |